Carbonic Anhydrase IX Promotes Tumor Growth and Necrosis <i>In Vivo</i> and Inhibition Enhances Anti-VEGF Therapy

Abstract

This work provides evidence that inhibition of the hypoxic adaptation to antiangiogenic therapy enhances bevacizumab treatment and highlights the value of developing small molecules or antibodies which inhibit CAIX for combination therapy.